Curis Lifesciences IPO to list today. Check GMP ahead of debut

Curis Lifesciences is set to list on the NSE SME platform on November 14, following an IPO that saw overwhelming investor response, subscribing 74.39 times. The company, which manufactures pharmaceutical formulations, reported strong financial growth in FY25. IPO proceeds will fund facility upgrades, working capital, and market expansion.